Sumitomo Mitsui Financial Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.6M Buy
412,532
+77,768
+23% +$4.22M 0.33% 39
2026
Q1
$21M Buy
334,764
+64,889
+24% +$5.19M 0.43% 40
2025
Q4
$25.7M Buy
269,875
+4,094
+2% +$401K 0.46% 33
2025
Q3
$25.9M Buy
265,781
+30,300
+13% +$3.14M 0.45% 31
2025
Q2
$25.3M Buy
235,481
+29,839
+15% +$3.02M 0.41% 28
2025
Q1
$20.7M Buy
205,642
+54,832
+36% +$5.52M 0.38% 28
2024
Q4
$13.5M Buy
+150,810
New +$13.3M 0.18% 42
2018
Q2
Sell
-7,300
Closed -$199K 112
2018
Q1
$199K Buy
+7,300
New +$198K 0.02% 72

Other funds holding BSX

Sumitomo Mitsui Financial Group's BSX Position: Q2 2026 in Review

Sumitomo Mitsui Financial Group increased its Boston Scientific (BSX) stake by 23% in Q2 2026, buying an estimated $4.22M and bringing the position to 412,532 shares worth $17.6M. The position accounts for 0.33% of the portfolio, ranked #39.

Sumitomo Mitsui Financial Group first reported a position in BSX in Q1 2018 and has held it in 8 quarters since. The position peaked at $25.9M in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Sumitomo Mitsui Financial Group held 412,532 shares of Boston Scientific worth $17.6M as of Q2 2026.
  • Sumitomo Mitsui Financial Group bought 77,768 Boston Scientific shares in Q2 2026, an estimated $4.22M.
  • Boston Scientific made up 0.33% of Sumitomo Mitsui Financial Group's portfolio in Q2 2026, its #39 holding.
  • Sumitomo Mitsui Financial Group first reported a position in Boston Scientific in Q1 2018 and has held it in 8 quarters since.
  • Sumitomo Mitsui Financial Group's Boston Scientific position peaked at $25.9M in Q3 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sumitomo Mitsui Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.